Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 2.05
-5.96 %
$ 146 M
Market Cap
-4.36
P/E
Price Target
Average
46.34%
Revenue Forecast
Estimate
6.99%
EBIT
Estimate
19.47%
Net Income
Estimate
22.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aclaris Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ACRS of $3 , with forecasts ranging from a low of $3 to a high of $3 .
ACRS Lowest Price Target
Wall Street Target
3 USD
46.34%
ACRS Average Price Target
Wall Street Target
3 USD
46.34%
ACRS Highest Price Target
Wall Street Target
3 USD
46.34%
REVENUE FORECAST
Revenue Forecast Chart ACRS
EBIT FORECAST
EBIT Forecast Chart ACRS
NET INCOME FORECAST
Net Income Chart ACRS